SEC

GQG Partners agrees to pay $500,000 to settle SEC charges over whistleblower rule violations

SEC cracks down on shortsellers, Hindenburg to potentially face scrutiny

The Securities and Exchange Commission (SEC) has intensified its crackdown on shortsellers, leaving Nate Anderson-led Hindenburg Research potentially vulnerable to scrutiny

SEC underdogs Mississippi State, Kentucky in ESPN 300 top 25 recruiting rankings

Oracle adds generative AI to fusion Cloud Applications, introduces sustainability solution

Oracle is integrating generative artificial intelligence capabilities into its Fusion Cloud Applications, offering more than 50 ways for its 14,000 customer companies to leverage the technology.

US SEC to announce major bitcoin ETF decision today

Despite the fact that the official deadline is set for August 13, it falls on a Sunday, therefore an announcement is expected a day early. Seyffart asserts that a delay is imminent and that the decision will most likely be made after the market closes.

Bengal SEC to look into poll violence complaints

Rajiva Sinha, the Bengal State Election Commissioner (SEC) has promised to look into complaints of vote tampering.

Fidelity refiles spot Bitcoin ETF application with US SEC

The SEC rejected dozens of spot Bitcoin ETF applications in the past few years, including one from Fidelity in January 2022.

SEC regulators harassing Elon Musk over 2018 regulatory settlement: Tesla

Tesla Inc. claims that regulators are harassing Chief Executive Elon Musk over his compliance with a 2018 regulatory settlement that sought to limit his use of social media.

Crypto Morning Digest: Bitcoin prices surge past 40k mark, BinanceUS CEO Brian Brooks resigns and other stories

The global cryptocurrency market cap stands at $1.77 trillion, a 7.27% increase from the previous day. Brian Brooks, chief executive officer of Binance US resigned three months after taking up the position. 

Covaxin phase 3 drug trial approved by SEC

The COVAXIN is an inactive vaccine that is developed by chemically treating the novel coronavirus samples to make it incapable of reproduction. That process leave the viral proteins intact, also including the spike protein of the coronavirus which it uses to enter the human cells.